UNIONDALE, N.Y. and ST. GALLEN, Switzerland, April 29, 2021 (GLOBE NEWSWIRE) -- Angion Biomedica Corp (NASDAQ:ANGN) and Vifor Pharma today announced completion of enrollment for Angion’s AKI-002 ...

Swiss drugmaker Vifor Pharma is aiming to complete more acquisitions or licensing deals this year, Chief Executive Stefan Schulze told Reuters. ZURICH, March 3 (Reuters) - Swiss drugmaker Vifor ...

EU antitrust regulators are investigating whether Vifor Pharma, which is being acquired by CSL Ltd, disparaged its rival Pharmacosmos in order to hinder competition to its blockbuster iron ...

(RTTNews) - Vifor Pharma announced positive outcome of the phase-IIIb DIAMOND trial of Veltassa in heart failure patients with either manifest hyperkalemia or with a history of hyperkalemia while ...

ZURICH/SYDNEY, Dec 13 (Reuters) - Vifor Pharma's shares (VIFN.S), opens new tab surged more than 15% in early trading on Monday after the Swiss drugmaker and Australia's CSL (CSL.AX), opens new ...

Australian biopharmaceutical company CSL Ltd. said it has made a US$11.7 billion all-cash offer for Switzerland’s Vifor Pharma Ltd. as it aims to add renal-disease and iron-deficiency ...

CSL Limited (ASX: CSL; USOTC:CSLLY) is pleased to announce it has now received all necessary regulatory clearances for the acquisition of Vifor Pharma AG (Vifor) announced on 14 December 2021.

BRUSSELS, April 19 (Reuters) - Vifor Pharma has offered to launch a marketing campaign to address any damage caused by its criticisms of a rival to its key drug, EU regulators said on Friday ...

Following the IPO, Galenica Group becomes Vifor Pharma Group and will be listed on the Swiss Stock Exchange under its new ticker, VIFN. The company has thus taken the final steps toward separating ...